この専門家をプロジェクトに採用したいですか？ 見積もりを依頼 無料で。
プロフィール詳細
Dr. Christopher R.に依頼
United Kingdom
Freelance infectious disease scientist with 40+ years experience in academia, industry and healthcare sectors
プロフィール概要
専門分野
サービス
Consulting
Healthcare Consulting,
Scientific and Technical Consulting
職務経験
Visiting Lecturer
Middlesex University
10月 2022 - 現在
Visiting Lecturer
Middlesex University
10月 2022 - 現在 
Visiting Lecturer
University of Bedfordshire
10月 2022 - 4月 2023
Visiting Lecturer
London South Bank University
10月 2022 - 4月 2023
Senior Lecturer in Microbiology / Programme Leader
Middlesex University
9月 2009 - 9月 2022
Senior Lecturer in Microbiology / Programme & Module Leader
Middlesex University
9月 2009 - 9月 2022
Principal Scientist
Glaxo SmithKline
10月 2001 - 4月 2009
Principal Scientist
GlaxoSmithKline
9月 2001 - 4月 2009
Principal Scientist
Glaxo Wellcome
10月 1999 - 9月 2001
Principal Scientist
Glaxo Wellcome
9月 1999 - 8月 2001
Principal Scientist
Glaxo Wellcome
10月 1996 - 9月 1999
Principal Scientist
Glaxo Wellcome
9月 1996 - 8月 1999
Research Fellow
Cancer Research UK
10月 1993 - 9月 1996
Research Fellow
University College London
9月 1992 - 8月 1996
Graduate Research Assistant
University College London
10月 1992 - 9月 1993
Graduate Research Assistant
University College London
10月 1990 - 9月 1992
Research Assistant
University College London
9月 1990 - 8月 1992
Research Assistant
Royal Postgraduate Medical School (now Imperial College)
10月 1986 - 9月 1990
Research Assistant
Royal Postgraduate Medical School (now Imperial College London)
9月 1986 - 8月 1990
Biomedical scientist
North Middlesex University Hospital
10月 1981 - 9月 1985
Biomedical Scientist
North Middlesex Hospital
9月 1981 - 8月 1985
学歴
Postgraduate Certificate in Higher Education
Middlesex University
1月 2010 - 1月 2011
Postgraduate Certificate in Higher Education (Natural Sciences)
Middlesex University
1月 2010 - 12月 2010
PhD (Molecular Virology) (Virology)
University Of London
10月 1986 - 6月 1991
PhD
University of London (Royal Postgraduate Medical School)
10月 1986 - 6月 1991
MSc.
University of Reading
10月 1985 - 10月 1986
MSc (Virology - Distinction)
University of Reading
10月 1985 - 9月 1986
Special Examination in Virology
Institute of Biomedical Science
9月 1983 - 7月 1985
Institute of Biomedical Science Special Examination in Virology
Paddington College (now University of Westminster)
9月 1983 - 6月 1985
Business and Technicians Education Council Higher Certificate in Medical Laboratory Science specialising in Medical Microbiology
Harrow College of Higher Education (now University of Westminster)
9月 1981 - 7月 1983
Higher Certificate in Medical Laboratory Science (specialising in Medical Microbiology)
Business and Technicians Education Council (BTEC)
9月 1981 - 7月 1983
認定資格
出版物
BOOK CHAPTER
Christopher J.A. Ring, Edward D. Blair(2023). Introduction: viruses as vehicles and expressors of genetic material . Genetically Engineered Viruses. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1--4. Garland Science
Neil J. Clarke, John E. Bisi, Caretha L. Creasy, Michael K. Dush, Kris J. Fisher, John M. Johnson, Christopher J. A. Ring, Mark R. Edbrooke(2005). RNA interference technology in the discovery and validation of druggable targets . RNA Interference Technology. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 347--360. Cambridge University Press
OTHER
Christopher Ring, Christiane Honisch, Vlad Serafim, Nicola Hennessy, David J. Allen, Leonardo P. Munoz, Saheer E. Gharbia, Ajit J. Shah, Haroun N. Shah(2017). Microbial DNA Analysis by MALDI‐TOF Mass Spectrometry . MALDI‐TOF and Tandem MS for Clinical Microbiology. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 187--209. Wiley
JOURNAL ARTICLE
Serafim V, Ring C, Pantoja L, Shah H, Shah A(2017). Rapid Identification of E. coli Bacteriophages using Mass Spectrometry . Journal of Proteomics & Enzymology. 06. (01). {OMICS} Publishing Group
Vlad Serafim, Ajit Shah, Chris Ring, Haroun N Shah(2016). TRANSITION FROM MALDI-TOF-MS TO LC-MS/MS FOR IDENTIFICATION OF VIRUSES . Unpublished. Unpublished
C. Cazzin, L. Piccoli, M. Massagrande, N. Garbati, F. Michielin, H.-G. Knaus, C. J. A. Ring, A. D. Morrison, E. Merlo-Pich, Z. Rovo, et al.(2011). rKv1.2 overexpression in the central medial thalamic area decreases caffeine-induced arousal . Genes, Brain and Behavior. 10. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 817--827. Wiley
M. Kollarik, M. J. Carr, F. Ru, C. J. A. Ring, V. J. Hart, P. Murdock, A. C. Myers, Y. Muroi, B. J. Undem(2010). Transgene expression and effective gene silencing in vagal afferent neurons<i>in vivo</i>using recombinant adeno-associated virus vectors . The Journal of Physiology. 588. (21). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 4303--4315. Wiley
Chiara Cazzin, Floriana Zanderigo, Vivian J.A. Costantini, Erika Zambello, Christopher J.A. Ring, Alastair D. Morrison, Laura Caberlotto, James N.C. Kew(2010). Adenoviral-mediated Cre expression effectively suppresses GlyT1 binding in the thalamic area of GlyT1 conditional knock-out mice . Journal of Neuroscience Methods. 193. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 254--263. Elsevier {BV}
Chiara Cazzin, Christopher J.A. Ring(2010). Recent advances in the manipulation of murine gene expression and its utility for the study of human neurological disease . Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 796--807. Elsevier {BV}
Miguel L Soares, Seiki Haraguchi, Maria-Elena Torres-Padilla, Tibor Kalmar, Lee Carpenter, Graham Bell, Alastair Morrison, Christopher JA Ring, Neil J Clarke, David M Glover, et al.(2005). Functional studies of signaling pathways in peri-implantation development of the mouse embryo by RNAi . BMC Developmental Biology. 5. (1). Springer Science and Business Media {LLC}
Caroline F. Maher, Tracy Hussell, Edward Blair, Christopher J.A. Ring, Peter J.M. Openshaw(2004). Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity . Microbes and Infection. 6. (12). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1049--1055. Elsevier {BV}
C Ward(2004). Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement . Journal of Clinical Virology. 29. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 179--188. Elsevier {BV}
TUOMO PUHAKKA, HEIKKI LEHTI, RAIJA VAINIONPÄÄ, VESA JORMANAINEN, MARKKU PULKKINEN, STEPHEN SHARP, CARON KERR, MARIA DEMPSEY, CHRISTOPHER JA RING, CHANTELLE WARD, et al.(2003). Zanamivir: a Significant Reduction in Viral Load During Treatment in Military Conscripts with Influenza . Scandinavian Journal of Infectious Diseases. 35. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 52--58. Informa {UK} Limited
Christopher J. A. Ring(2002). Cytolytic viruses as potential anti-cancer agents . Journal of General Virology. 83. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 491--502. Microbiology Society
CJA Ring, P Blouin, L-A Martin, HC Hurst, NR Lemoine(1997). Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme . Gene Therapy. 4. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1045--1052. Springer Science and Business Media {LLC}
Ring CJ, Harris JD, Hurst HC, Lemoine NR (1996). Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter. Gene therapy.
Pandha HS, Ring CJ, Sikora K (1996). Gene therapy for cancer. The New Zealand medical journal.
D. F.P. Larkin, H. B. Oral, C. J.A. Ring, N. R. Lemoine, A. J.T. George(1996). ADENOVIRUS-MEDIATED GENE DELIVERY TO THE CORNEAL ENDOTHELIUM1 . Transplantation. 61. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 363--370. Ovid Technologies (Wolters Kluwer Health)
Ali M, Lemoine NR, Ring CJ (1994). The use of DNA viruses as vectors for gene therapy. Gene therapy.
P J Morris, T Theil, C J Ring, K A Lillycrop, T Moroy, D S Latchman(1994). The opposite and antagonistic effects of the closely related POU family transcription factors Brn-3a and Brn-3b on the activity of a target promoter are dependent on differences in the POU domain . Molecular and Cellular Biology. 14. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 6907--6914. Informa {UK} Limited
C. J. A. Ring(1994). The B cell-immortalizing functions of Epstein-Barr virus . Journal of General Virology. 75. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1--13. Microbiology Society
M Makris, JA Garson, CJ Ring, PW Tuke, RS Tedder, FE Preston(1993). Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients . Blood. 81. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1898--1902. American Society of Hematology
N. S. Brink, R. Chopra, C. J. Perrons, C. J. A. Ring, J. A. Garson, E. M. Briggs, A. H. Goldstone, D. C. Linch, R. S. Tedder(1993). Acute hepatitis C infection in patients undergoing therapy for haematological malignancies: a clinical and virological study . British Journal of Haematology. 83. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 498--503. Wiley
Peter J. Morris, Carolyn L. Dent, Christopher J. Ring, David S. Latchman(1993). The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells . Nucleic Acids Research. 21. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1019--1023. Oxford University Press ({OUP})
C.J.A. Ring, D.S. Latchman(1993). The human Brn-3b POU transcription factor shows only limited homology to the Brn-3a/RDC-1 factor outside the conserved POU domain . Nucleic Acids Research. 21. (12). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2946--2946. Oxford University Press ({OUP})
Peter J. Morris, Christopher J.A. Ring, Karen A. Lillycrop, David S. Latchman(1993). Transactivation of the human papilloma virus 16 octamer motif by the octamer binding protein Oct-2 requires both the N and C terminal activation domains . Nucleic Acids Research. 21. (19). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 4506--4510. Oxford University Press ({OUP})
C.J.A. Ring, D.S. Latchman(1993). The human Brn-3b POU transcription factor shows only limited homology to the Brn-3a/RDC-1 factor outside the conserved POU domain . Nucleic Acids Research. 21. (12). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2946--2946. Oxford University Press ({OUP})
C. J. A. Ring, M. D. Jones, B. E. Griffin(1992). Alternative Splicing Determines The Carboxy Terminus of the Epstein--Barr Virus Nuclear Antigen 5 Species Expressed in the Burkitt's Lymphoma Cell Line Daudi . Journal of General Virology. 73. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2715--2719. Microbiology Society
J. A. Garson, A. N. Wicki, C. J. A. Ring, H. Joller, G. Zala, M. Schmid, H. Buehler(1992). Detection of hepatitis C viraemia in caucasian patients with hepatocellular carcinoma . Journal of Medical Virology. 38. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 152--156. Wiley
J. A. Garson, A. N. Wicki, C. J. A. Ring, H. Joller, G. Zala, M. Schmid, H. Buehler(1992). Detection of hepatitis C viraemia in caucasian patients with hepatocellular carcinoma . Journal of Medical Virology. 38. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 152--156. Wiley
J. A. Garson, S. Brillanti, C. Ring, P. Perini, M. Miglioli, L. Barbara(1992). Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis . Journal of Medical Virology. 37. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 210--214. Wiley
J. A. Garson, J. P. Clewley, P. Simmonds, L. Q. Zhang, J. Mori, C. Ring, E. A. C. Follett, B. C. Dow, S. Martin, H. Gunson(1992). Hepatitis C Viraemia in United Kingdom Blood Donors: A Multicentre Study . Vox Sanguinis. 62. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 218--223. Wiley
JeremyA. Garson, ChristopherJ.A. Ring, PhilipW. Tuke(1991). Improvement of HCV genome detection with "short" PCR products . The Lancet. 338. (8780). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1466--1467. Elsevier {BV}
R. S. Tedder, M. Briggs, C. Ring, P. W. Tuke, P. Jones, G. F. Savidge, B. Rodgers, J. A. Garson(1991). Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia . British Journal of Haematology. 79. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 512--515. Wiley
Christopher Ring, AwadA Saeed, AhmedM Al-Admawi, Abdulmohsin Al-Rasheed, Debbie Fairclough, Robby Bacchus, Jeremy Garson(1991). Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh . The Lancet. 338. (8764). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 459--460. Elsevier {BV}
J. A. Garson, M. Lenzi, C. Ring, F. Cassani, G. Ballardini, M. Briggs, R. S. Tedder, F. B. Bianchi(1991). Hepatitis C viraemia in adults with type 2 autoimmune hepatitis . Journal of Medical Virology. 34. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 223--226. Wiley
S. Brillanti, J. A. Garson, P. W. Tuke, C. Ring, M. Briggs, C. Masci, M. Miglioli, L. Barbara, R. S. Tedder(1991). Effect of α‐interferon therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis: A quantitative polymerase chain reaction study . Journal of Medical Virology. 34. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 136--141. Wiley
S. Brillanti, J.A. Garson, P.W. Take, C. Masci, C. Ring, M. Briggs, M. Miglioli, R.S. Tedder, L. Barbara(1991). Antiviral effect of alpha interferon treatment in chronic hepatitis C: A quantitative PCR study . Journal of Hepatology. 13. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString S102. Elsevier {BV}
J.A Garson, C Ring, P Tuke, R.S Tedder(1990). Enhanced detection by PCR of hepatitis C virus RNA . The Lancet. 336. (8719). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 878--879. Elsevier {BV}
J GARSON(1990). Detection by PCR of hepatitis C virus in factor VIII concentrates . The Lancet. 335. (8703). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1473. Elsevier {BV}
評価とコメント
受注プロジェクト総数:
コメント: